The Enteral Feeding Formulas Market is forecasted to grow from USD 6.16 Billion in 2022 to USD 10.97 Billion by 2030, at a CAGR of 7.5%, during the forecast period. The market is primarily driven by the growing geriatric population, chronic diseases, and premature births, high spending on health care and high demand for home care.
Increase in patients suffering from cardiovascular diseases, cancer and diabetes, the leading disease-causing death, has driven the enteral formula market. Continuous clinical trials show the growth of new developments in products. Another key factor that positively impacts the growth of tube feeds is the increasing number of new product launches.
Enteral tube feeding is used for the administration of nutrients through the intestine or the stomach through the tubes and this applies to those patients who are unable to meet the nutrient requirements or are unable to orally consume nutrients. Various types of tubes, such as nasojejunal tube, nasogastric tube, gastrostomy and jejunostomy, are available for enteral formula feeding.
Large varieties of formulas are available to feed a person in enteral procedures, selection of a particular method for a person, who is not suitable for such a formula results in various side effects. Few people are allergic to specific proteins, fatty acids (milk and lactose, maize, eggs, tree nuts, soy, fish, and others) and are required to take formulas that are appropriate for their condition. Consequently, complexity in selecting the right method reduces market growth.
Request a Sample@ https://qyresearchmedical.com/sample/119059
Key Coverage of the Report
- Region and country wise market size of the market from the period 2019-2030. 2022 is the base year, and 2019-2030, is the forecast period
- Market by type, form, age, application, flavor and regional analysis (2015 -2017)
- Contributing factors for the high adaptation of Enteral Feeding Formulas
- Demand and Supply Gap Analysis
- Regional Competitors Pricing Strategy
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 6 years of all the mentioned segments, sub-segments and the regional markets
- Market Trends (Drivers, Restraints, Opportunities, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Value chain trends mapping the latest technological advancements
Salient Trends of Enteral Feeding Formulas Market
- The Enteral Feeding Formulas Market is forecasted to grow from USD 6.16 Billion in 2022 to USD 10.97 Billion by 2030, at a CAGR of 7.5%, during the forecast period. The market is primarily driven by the growing geriatric population, chronic diseases, and premature births, high spending on health care and high demand for home care.
- Increase in patients suffering from cardiovascular diseases, cancer and diabetes, the leading disease-causing death, has driven the enteral formula market. Continuous clinical trials show the growth of new developments in products. Another key factor that positively impacts the growth of tube feeds is the increasing number of new product launches.
- Enteral tube feeding is used for the administration of nutrients through the intestine or the stomach through the tubes and this applies to those patients who are unable to meet the nutrient requirements or are unable to orally consume nutrients. Various types of tubes, such as nasojejunal tube, nasogastric tube, gastrostomy and jejunostomy, are available for enteral formula feeding.
- Large varieties of formulas are available to feed a person in enteral procedures, selection of a particular method for a person, who is not suitable for such a formula results in various side effects. Few people are allergic to specific proteins, fatty acids (milk and lactose, maize, eggs, tree nuts, soy, fish, and others) and are required to take formulas that are appropriate for their condition. Consequently, complexity in selecting the right method reduces market growth.
Companies considered and profiled in this market study
The major players in the market are Fresenius Kabi AG (Germany), Victus Inc. (US), B. Braun Melsungen AG (Germany), Global Health Product Inc. (US), Abbott Laboratories (US), Nestle (Switzerland), Danone S.A. (France), Mead Johnson Nutrition Company (US), Hormel Foods, LLC (US), Meiji Holdings Co., Ltd. (Japan) and others.
Market-O-Nomics
- The Enteral Feeding Formulas Market is forecasted to grow from USD 6.16 Billion in 2022 to USD 10.97 Billion by 2030, at a CAGR of 7.5%, during the forecast period. The market is primarily driven by the growing geriatric population, chronic diseases, and premature births, high spending on health care and high demand for home care.
- The market for diabetes is expected to grow at the highest CAGR of 8.1% during the forecast period. Developing affordable and effective diabetes therapy, increasing people’s awareness of diabetes self-management, and government support is further boosting market growth.
- The market for infants is expected to grow at a CAGR of 7.5% during the forecast period. Factors such as an increased number of premature births and an increased prevalence of malnutrition among hospitalized children stimulate the demand for these formulas.
- The market for standard formula is expected to grow the largest at a CAGR of 8% during the forecast period. Growing micro and macro-nutrient deficiency among hospital patients during both pre and post-surgery stimulates their demand. These tube feeds commonly contain proteins and polysaccharides for patients with no difficulty digesting and absorbing nutrients. The availability of wide range of standard formulas in combination with increased demand for low-cost nutrient formulations drives their growth
- The market for Asia-Pacific (APAC) is expected to grow at a CAGR of 8.1% during the forecast period. One of the major factors driving regional demand is the increasing incidence of premature births. India, China, Pakistan, and Indonesia are among the top countries with the largest number of premature births. Factors such as rising healthcare spending and recent healthcare infrastructure improvements in many countries, including China, Japan, India, and Singapore, are expected to drive the market in the coming years.
Segments covered in the report:
This report forecasts volume and revenue growth at a global, regional & country level, and provides an analysis on the industry trends in each of the sub-segments from 2016 to 2030. For the purpose of this study, Reports and Data have segmented the market on the basis of type, form, age, application, flavor and regional analysis.
Type (Revenue, USD Million; 2022-2030)
- Standard Formula
- Specialty Formula
- Blenderized Formula
- Elemental Formula
- Semi-Elemental Formula
- Polymeric Formula
- Fiber Supplemented Formula
- Others
Age (Revenue, USD Million; 2022-2030)
- Adult
- Infants
Form (Revenue, USD Million; 2022-2030)
- Powder
- Liquid
- Others
Flavor (Revenue, USD Million; 2022-2030)
- Vanilla
- Strawberry
- Butter pecan
- Unflavored
Application (Revenue, USD Million; 2022-2030)
- Oncology
- Neurology
- Diabetes
- Critical care
Region (Revenue, USD Million; 2022-2030)
- North America
- US
- Europe
- France
- UK
- Asia Pacific
- China
- India
- Japan
- Latin America
- Brazil
- Middle East & Africa
Buy quantitative research Report at discounted price – USD 1500 https://qyresearchmedical.com/report/checkout/119059/1500
You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333
Blog: https://www.novaoneadvisor.com/
Blog: https://www.visionresearchreports.com/
About Us
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us:
URL – http://www.qyresearchmedical.com/
https://www.linkedin.com/company/qyresearch-medical/
https://www.facebook.com/QYResearch-Medical-108186514228917/